2010 Oncochannel Acronyme Du Projet

2010 Oncochannel Acronyme Du Projet

APPEL A PROJETS LABEX/ OncoChannel CALL FOR PROPOSALS DOCUMENT SCIENTIFIQUE B / 2010 SCIENTIFIC SUBMISSION FORM B Acronyme du projet/ Acronym of the Oncochannel project Titre du projet en Oncocanalopathies : approche interdisciplinaire « high- français tech » pour la médecine innovante Oncochannelopathies : high-technology interdisciplinary Project title in English approach for innovative medicine Nom/Name : PRES ULNF Coordinateur du Etablissement/institution : PRES ULNF/University of Lille projet/Coordinator of Laboratoire/Laboratory : Cell Physiology the project Numero d’unité/Unit number: Inserm U1003 Aide demandée/ 12,400,000 euros HT Requested funding X Santé, bien-être, alimentation et biotechnologies / Health, well- being, nutrition and biotechnologies □ Urgence environnementale et écotechnologies / Environnemental Champs disciplinaires urgency, ecotechnologies (SNRI) / Disciplinary □ Information, communication et nanotechnologies / Information, field communication and nantechnologies □ Sciences humaines et sociales / Social sciences □ Autre champ disciplinaire / Other disciplinary scope Domaines scientifiques/ Cellular physiology, membrane biology, biochemistry, scientific areas biophysics, nanotechnologies Participation à un ou plusieurs projet(s) « Initiatives d’excellence » (IDEX) / □ oui X non Participation in an « Initiatives d’excellence » project 1/198 APPEL A PROJETS LABEX/ OncoChannel CALL FOR PROPOSALS DOCUMENT SCIENTIFIQUE B / 2010 SCIENTIFIC SUBMISSION FORM B Affiliation(s) du partenaire coordinateur de projet/ Organisation of the coordinating partner Laboratoire(s)/Etablissement(s) Numéro(s) d’unité/ Tutelle(s) /Research Laboratory/Institution(s) Unit number Organisation reference Laboratory of Cell Physiology/ PRES/ University of U1003 PRES ULNF/University of Lille Lille1/Inserm Affiliations des partenaires au projet/Organization of the partner(s) Laboratoire(s)/Etablissement(s) Numéro(s) d’unité/ Tutelle(s)/Research Laboratory/Institution(s) Unit number Organisation reference Laboratory of Cell Physiology (LCP) U1003 Inserm - Lille 1University Glycobiology of Cell Signalling and UMR 8576 CNRS - Lille 1 University Glycopathologies (GCSG) Genetics and Evolution of Plant FRE 3268 CNRS - Lille 1 University Populations (GEPV) MALDI Imaging Team (MIT) FRE 3249 CNRS - Lille 1 University Laboratory of Biochemistry and Integrated Structural Biology UMR3078 CNRS - Lille 1 University (LBISB) NanoBioInterfaces (NBI) UMR 3078 CNRS - Lille 1 University Biostructures and drug discovery Inserm – UDSL, Institut U761 (BDD) Pasteur de Lille Interventional Therapies Assisted by U703 Inserm – Lille2 University Image and Simulation (ITAIS) 2/198 APPEL A PROJETS LABEX/ OncoChannel CALL FOR PROPOSALS DOCUMENT SCIENTIFIQUE B / 2010 SCIENTIFIC SUBMISSION FORM B 1. RESUME / SUMMARY ................................................................................ 5 2. CANDIDATURE AUX ACTIONS DU PROGRAMME INVESTISSEMENTS D’AVENIR/ APPLICATION TO THE ACTIONS OF THE PROGRAMME « INVESTISSEMENTS D’AVENIR » ........................................................................................... 9 3. ORGANISATION DU PARTENARIAT/ MANAGEMENT OF THE PARTNERSHIP .................... 9 3.1. Composition du partenariat/ Composition of the partnership ................ 9 3.2. Qualification du coordinateur de projet /Relevant experience of the project coordinator ..................................................................................... 12 Coordination of national and international projects. ......................................... 12 She developed a number of regional, national and international collaborations and successfully coordinated: two national French projects funded by ......................................................................................................... 12 - INCA (National Institute of Cancer Research) grant, 2006-2009 « The roles of trpm8 and trpv6 ion channels in prostate cancer: functional studies and molecular targeting for the elaboration of new therapeutic strategies” with 4 French laboratories CNRS UPR 9079 ; INSERM U407 ; INSERM U664 ; EA 2086; .................................................................................. 13 4. DESCRIPTION DE L’EXISTANT/ DESCRIPTION OF THE EXISTING ............................. 13 4.1. Présentation des partenaires ............................................................... 13 4.1.1 Partenaire 1/ Partner 1: PRES 13 4.1.2 Partenaire 2/ Partner 2: Natalia PREVARSKAYA 13 4.1.2.1 Recherche et innovation / Research and innovation 13 4.1.2.2 Valorisation / Exploitation of results 22 4.1.2.3 Enseignement superieur / Higher education 23 4.1.2.4 Organisation / Organisation 24 4.1.3 Partenaire 3/ Partner 3 : Jean-Claude MICHALSKI 26 4.1.3.1 Recherche et innovation / Research and innovation 26 4.1.3.2 Valorisation / Exploitation of results 28 4.1.3.3 Enseignement superieur / Higher education 28 4.1.3.4 Organisation / Organisation 28 4.1.4 Partenaire 4/ Partner 4 : Xavier VEKEMANS 30 4.1.4.1 Recherche et innovation / Research and innovation 30 4.1.4.2 Valorisation / Exploitation of results 32 4.1.4.3 Enseignement superieur / Higher education 32 4.1.4.4 Organisation / Organisation 32 4.1.5 Partenaire 5/ Partner 5 : Isabelle FOURNIER 32 4.1.5.1 Recherche et innovation / Research and innovation. 32 4.1.5.2 Valorisation / Exploitation of results 36 4.1.5.3 Enseignement superieur / Higher education 36 4.1.5.4 Organisation / Organisation 37 4.1.6 Partenaire 6/ Partner 6 : Vincent VILLERET 38 4.1.6.1 Recherche et innovation / Research and innovation 38 4.1.6.2 Valorisation / Exploitation of results 42 4.1.6.3 Enseignement superieur / Higher education 43 4.1.6.4 Organisation / Organisation 43 4.1.7 Partenaire 7/ Partner 7 : Rabah BOUKHERROUB 44 4.1.7.1 Recherche et innovation / Research and innovation 44 4.1.7.2 Valorisation / Exploitation of results 48 4.1.7.3 Enseignement superieur / Higher education 48 4.1.7.4 Organisation / Organisation 49 4.1.8 Partenaire 8/ Partner 8 : Benoit DEPREZ 52 4.1.8.1 Recherche et innovation / Research and innovation 52 4.1.8.2 Valorisation / Exploitation of results 53 4.1.8.3 Enseignement superieur / Higher education 54 4.1.8.4 Organisation / Organisation 54 3/198 APPEL A PROJETS LABEX/ OncoChannel CALL FOR PROPOSALS DOCUMENT SCIENTIFIQUE B / 2010 SCIENTIFIC SUBMISSION FORM B 4.1.9 Partenaire 9/ Partner 9 : Serge MORDON 55 4.1.9.1 Recherche et innovation / Research and innovation 55 4.1.9.2 Valorisation / Exploitation of results 58 4.1.9.3 Enseignement superieur / Higher education 58 4.1.9.4 Organisation / Organisation 59 4.2. Collaborations existantes / Existing collaborations ............................. 59 5. DESCRIPTION SCIENTIFIQUE ET TECHNIQUE DU PROJET / TECHNICAL AND SCIENTIFIC DESCRIPTION OF THE PROJECT .................................................... 60 5.1. Etat de l’art / State of the art .............................................................. 60 5.2. Objectifs du projet par rapport à l’état de l’art et liens avec la SNRI/ Objectives of the project compared to the state of the art and in relation to the SNRI .......................................................................................... 68 5.2.1 Présentation scientifique du projet de recherche/ Scientific programme 68 5.2.2 Valorisation, transfert et expertise/ Exploitation of results, transfer and expertise 82 5.2.3 Enseignement supérieur, Insertion / Higher education, Integration into the workplace 86 5.2.4 Gouvernance du Labex/ Governance 90 5.2.5 Attractivité/Attraction 93 5.3. Stratégie des établissements tutelles/ Strategy of the supervising institution ......................................................................................................... 95 5.4. Relation avec le monde socio-économique/ Connections to the socio-economic world ..................................................................................... 101 5.5. Effet d’entraînement potentiel/ Pull effect ........................................ 103 6. JUSTIFICATION SCIENTIFIQUE ET FINANCIERE DES MOYENS DEMANDES / FINANCIAL AND SCIENTIFIC JUSTIFICATION FOR THE MOBILISATION OF THE RESOURCES .......... 105 6.1. Justification des moyens demandés (sur 10 ans) / Justification for the mobilisation of the resources .................................................................... 105 6.1.1 Projet de recherche/ Research project 105 6.1.2 Projet pédagogique/ Educational project 109 6.1.3 Valorisation/ Exploitation of results 109 6.1.4 Gouvernance/ governance 110 6.2. Autres ressources / others resources ................................................ 110 7. ANNEXES / APPENDICES ........................................................................ 114 7.1. Références bibliographiques de l’etat de l’art/State of the art references ...................................................................................................... 114 7.2. Références bibliographiques des partenaires/Partners’ references ... 116 7.3. Devis/Estimate .................................................................................. 171 4/198 APPEL A PROJETS LABEX/ OncoChannel CALL FOR PROPOSALS DOCUMENT SCIENTIFIQUE B / 2010 SCIENTIFIC SUBMISSION FORM B 1. RESUME / SUMMARY Title of the project: Oncochannelopathies: high-technology interdisciplinary approach for innovative medicine. The OncoChannel Laboratory of Excellence is a research structure unique in France, centralizing intellectual and up-to-date technological expertise in the field of “Ion channels and Cancer”. Given the present achievements

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    198 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us